Phase II study with Taxol® (paclitaxel) and Gemzar® (gemcitabine) in metastatic non-small cell lung cancer (NSCLC)
- 30 September 2000
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 29 (1), 45-46
- https://doi.org/10.1016/s0169-5002(00)80147-6